Current and historical daily PE Ratio for BIOYF (
Biosyent Inc
) from 1990 to May 15 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Biosyent stock (BIOYF) PE ratio as of May 15 2024 is 15.61.
More Details
Biosyent Inc (BIOYF) PE Ratio (TTM) Chart
Biosyent Inc (BIOYF) PE Ratio (TTM) Historical Data
View and export this data going back to 1990. Start your Free Trial
Total 1228
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Biosyent PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-15 | 15.6 | 2024-03-12 | 16.5 |
| 2024-05-14 | 15.6 | 2024-03-11 | 16.3 |
| 2024-05-13 | 16.1 | 2024-03-08 | 16.4 |
| 2024-05-10 | 16.1 | 2024-03-07 | 16.4 |
| 2024-05-09 | 16.1 | 2024-03-06 | 16.3 |
| 2024-05-08 | 16.1 | 2024-03-05 | 16.1 |
| 2024-05-07 | 16.1 | 2024-03-04 | 16.1 |
| 2024-05-06 | 16.1 | 2024-03-01 | 16.1 |
| 2024-05-03 | 16.2 | 2024-02-29 | 16.1 |
| 2024-05-02 | 16.1 | 2024-02-28 | 16.1 |
| 2024-05-01 | 16.1 | 2024-02-27 | 15.9 |
| 2024-04-30 | 16.0 | 2024-02-26 | 15.9 |
| 2024-04-29 | 16.1 | 2024-02-23 | 15.9 |
| 2024-04-26 | 15.9 | 2024-02-22 | 15.9 |
| 2024-04-25 | 15.9 | 2024-02-21 | 16.2 |
| 2024-04-24 | 15.9 | 2024-02-20 | 16.2 |
| 2024-04-23 | 15.9 | 2024-02-16 | 16.2 |
| 2024-04-22 | 15.9 | 2024-02-15 | 16.2 |
| 2024-04-19 | 15.9 | 2024-02-14 | 16.2 |
| 2024-04-18 | 15.9 | 2024-02-13 | 16.2 |
| 2024-04-17 | 15.7 | 2024-02-12 | 16.5 |
| 2024-04-16 | 15.7 | 2024-02-09 | 16.5 |
| 2024-04-15 | 15.7 | 2024-02-08 | 16.5 |
| 2024-04-12 | 15.9 | 2024-02-07 | 16.5 |
| 2024-04-11 | 16.0 | 2024-02-06 | 16.5 |
| 2024-04-10 | 16.0 | 2024-02-05 | 16.2 |
| 2024-04-09 | 16.1 | 2024-02-02 | 16.2 |
| 2024-04-08 | 16.1 | 2024-02-01 | 16.3 |
| 2024-04-05 | 16.1 | 2024-01-31 | 16.0 |
| 2024-04-04 | 16.2 | 2024-01-30 | 16.2 |
| 2024-04-03 | 16.1 | 2024-01-29 | 16.2 |
| 2024-04-02 | 16.2 | 2024-01-26 | 16.2 |
| 2024-04-01 | 16.2 | 2024-01-25 | 16.2 |
| 2024-03-28 | 16.2 | 2024-01-24 | 16.2 |
| 2024-03-27 | 16.2 | 2024-01-23 | 15.9 |
| 2024-03-26 | 16.3 | 2024-01-22 | 15.9 |
| 2024-03-25 | 16.3 | 2024-01-19 | 15.8 |
| 2024-03-22 | 16.1 | 2024-01-18 | 15.8 |
| 2024-03-21 | 16.2 | 2024-01-17 | 15.8 |
| 2024-03-20 | 16.1 | 2024-01-16 | 16.2 |
| 2024-03-19 | 16.1 | 2024-01-12 | 16.4 |
| 2024-03-18 | 16.1 | 2024-01-11 | 16.4 |
| 2024-03-15 | 16.0 | 2024-01-10 | 16.6 |
| 2024-03-14 | 16.3 | 2024-01-09 | 16.4 |
| 2024-03-13 | 16.3 | 2024-01-08 | 16.4 |
Biosyent Inc (BIOYF) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Biosyent Inc
NAICS : 325412
SIC : 3741
ISIN : CA0906901081
Description
Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product includes FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn, and Tibella.m.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers